- Imatinib Plasma Monitoring-Guided Dose Modification for Managing Imatinib-Related Toxicities in Gastrointestinal Stromal Tumor Patients
-
Yoon S, Ryu MH, Yoo C, Beck MY, Ryoo BY, Kang YK
- KMID: 1793034
- J Korean Med Sci.
- 2013 Aug;28(8):1248-1252.
- doi: 10.3346/jkms.2013.28.8.1248
Imatinib, the first-line treatment in patients with advanced gastrointestinal stromal tumors (GIST), is generally well tolerated, although some patients have difficulty tolerating the standard dose of 400 mg/day. Adjusting imatinib... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatic Lesions that Mimic Metastasis on Radiological Imaging during Chemotherapy for Gastrointestinal Malignancy: Recent Updates
-
You SH, Park BJ, Kim YH
- KMID: 2427297
- Korean J Radiol.
- 2017 Jun;18(3):413-426.
- doi: 10.3348/kjr.2017.18.3.413
During chemotherapy in patients with gastrointestinal malignancy, the hepatic lesions may occur as chemotherapy-induced lesions or tumor-associated lesions, with exceptions for infectious conditions and other incidentalomas. Focal hepatic lesions arising... -
- CITED
-
- Close
- SHARE
-
- Close
